You are here »
Home »
Companies » Alembic Pharmaceuticals Ltd - Announcements
Alembic Pharmaceuticals Ltd.
| BSE: 533573 |
Sector: Health care |
| NSE: APLLTD |
ISIN Code: INE901L01018 |
|
BSE
00:00 | 24 Apr 2020
|
Alembic Pharmaceuticals Ltd
|
|
NSE
05:30 | 01 Jan 1970
|
Alembic Pharmaceuticals Ltd
|
Announcement under Regulation 30 (LODR)-Press Release / Media Release
April 20, 2020, 8:46 am | Source: BSE
With reference to the captioned subject this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Alcaftadine Ophthalmic Solution 0.25%.
Please find enclosed herewith our press release.
We request you to kindly take the same on record.
